◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › A › ATR

AptarGroup Inc (ATR) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · DATA UPDATED 2026-08-05

AptarGroup Inc (ATR) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Crystal Lake, United States with about 14,000 employees. Its market capitalization is roughly $8 billion. In the fiscal year ended 2025-12-31, ATR reported $3.8B in revenue and $393M in net income.

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets.

Interactive charts & full statements → Open the ATR valuation workbench →

ATR Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$3.9B	$3.8B	$3.6B	$3.5B	$3.3B	$3.2B	$2.9B	$2.9B	$2.8B	$2.5B	$2.3B	$2.3B	$2.6B	$2.5B	$2.3B	$2.3B	$2.1B	$1.8B	$2.1B	$1.9B	$1.6B
Gross Profit	$1.1B	$1.1B	$1.4B	$1.3B	$1.2B	$1.2B	$1.1B	$1.0B	$952M	$865M	$833M	$814M	$843M	$811M	$741M	$769M	$698M	$616M	$660M	$608M	$515M
Gross Margin %	28.3%	29.6%	37.8%	36.2%	35.0%	35.8%	37.1%	36.4%	34.4%	35.0%	35.7%	35.1%	32.4%	32.2%	31.8%	32.9%	33.6%	33.5%	31.9%	32.1%	32.2%
Operating Income (EBIT)	$487M	$512M	$496M	$404M	$379M	$347M	$339M	$372M	$286M	$322M	$310M	$324M	$306M	$285M	$259M	$287M	$268M	$206M	$228M	$211M	$162M
Operating Margin %	12.4%	13.6%	13.9%	11.6%	11.4%	10.8%	11.6%	13.0%	10.3%	13.0%	13.3%	14.0%	11.8%	11.3%	11.1%	12.3%	12.9%	11.2%	11.0%	11.1%	10.1%
Net Income	$363M	$393M	$375M	$284M	$239M	$244M	$214M	$242M	$195M	$220M	$206M	$199M	$192M	$172M	$163M	$184M	$173M	$125M	$153M	$142M	$103M
Net Margin %	9.2%	10.4%	10.4%	8.2%	7.2%	7.6%	7.3%	8.5%	7.0%	8.9%	8.8%	8.6%	7.4%	6.8%	7.0%	7.9%	8.3%	6.8%	7.4%	7.5%	6.4%
EBITDA	$822M	$831M	$777M	$664M	$609M	$587M	$556M	$572M	$476M	$490M	$470M	$468M	$460M	$447M	$397M	$426M	$402M	$334M	$371M	$343M	$276M
Earnings Per Share (EPS)	$5.53	$5.89	$5.53	$4.25	$3.59	$3.61	$3.21	$3.66	$3.00	$3.41	$3.17	$3.09	$2.85	$2.52	$2.38	$2.65	$2.48	$1.79	$2.18	$1.98	$1.43
Shares Outstanding (M)	65M	67M	68M	67M	67M	68M	67M	66M	65M	65M	65M	64M	67M	68M	68M	69M	70M	70M	71M	72M	72M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ATR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$1.0B	$983M	$963M	$961M	$966M	$887M	$848M	$909M
Gross Profit	$286M	$276M	$262M	$288M	$297M	$271M	$329M	$351M
Gross Margin %	27.9%	28.1%	27.2%	29.9%	30.8%	30.5%	38.8%	38.6%
Operating Income (EBIT)	$128M	$109M	$111M	$139M	$146M	$115M	$120M	$138M
Operating Margin %	12.5%	11.1%	11.5%	14.5%	15.1%	13.0%	14.2%	15.2%
Net Income	$88M	$73M	$74M	$128M	$112M	$79M	$101M	$100M
Net Margin %	8.5%	7.4%	7.7%	13.3%	11.6%	8.9%	11.9%	11.0%
EBITDA	$208M	$186M	$185M	$243M	$220M	$183M	$195M	$210M
Earnings Per Share (EPS)	$1.36	$1.12	$1.13	$1.92	$1.67	$1.17	$1.49	$1.48
Shares Outstanding (M)	65M	65M	66M	67M	67M	67M	68M	68M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ATR Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$583M	$570M	$643M	$575M	$479M	$363M	$570M	$514M	$314M	$325M	$325M	$324M	$316M	$286M	$314M	$261M	$279M	$280M	$270M	$273M	$197M
Capital Expenditures (CapEx)	$273M	$270M	$294M	$318M	$316M	$308M	$252M	$247M	$212M	$157M	$131M	$149M	$162M	$152M	$174M	$180M	$119M	$145M	$205M	$139M	$112M
Free Cash Flow (FCF)	$310M	$300M	$349M	$257M	$163M	$56M	$318M	$267M	$102M	$168M	$194M	$174M	$154M	$134M	$140M	$81M	$159M	$135M	$65M	$134M	$85M
FCF Margin %	7.9%	7.9%	9.8%	7.4%	4.9%	1.7%	10.9%	9.3%	3.7%	6.8%	8.3%	7.5%	5.9%	5.3%	6.0%	3.5%	7.7%	7.3%	3.1%	7.1%	5.3%
Dividends Paid	$123M	$121M	$114M	$104M	$99M	$99M	$93M	$90M	$82M	$80M	$77M	$71M	$71M	$66M	$58M	$53M	$44M	$41M	$38M	$34M	$29M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ATR Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$103M	$119M	$184M	$178M	$126M	$83M	$178M	$229M
Capital Expenditures (CapEx)	$58M	$65M	$87M	$63M	$65M	$59M	$71M	$80M
Free Cash Flow (FCF)	$46M	$53M	$97M	$114M	$61M	$23M	$108M	$149M
FCF Margin %	4.5%	5.4%	10.1%	11.9%	6.3%	2.6%	12.7%	16.4%
Dividends Paid	$31M	$31M	$31M	$30M	$30M	$30M	$30M	$30M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ATR Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$5.1B	$5.3B	$4.4B	$4.5B	$4.2B	$4.1B	$4.0B	$3.6B	$3.4B	$3.1B	$2.6B	$2.4B	$2.4B	$2.5B	$2.3B	$2.2B	$2.0B	$2.0B	$1.8B	$1.9B	$1.6B
Cash & Cash Equivalents	$190M	$402M	$224M	$224M	$142M	$123M	$300M	$242M	$262M	$713M	$466M	$490M	$400M	$310M	$230M	$378M	$376M	$333M	$192M	$314M	$171M
Total Liabilities	$2.5B	$2.5B	$1.9B	$2.1B	$2.1B	$2.2B	$2.1B	$2.0B	$2.0B	$1.8B	$1.4B	$1.3B	$1.3B	$1.0B	$944M	$869M	$753M	$703M	$700M	$792M	$645M
Total Debt (Short + Long-Term)	$249M	$1.5B	$1.0B	$1.1B	$1.2B	$1.2B	$1.2B	$1.2B	$1.3B	$1.3B	$947M	$818M	$842M	$495M	$428M	$439M	$404M	$338M	$292M	$363M	$296M
Total Shareholders' Equity	$2.6B	$2.7B	$2.5B	$2.3B	$2.1B	$2.0B	$1.9B	$1.6B	$1.4B	$1.3B	$1.2B	$1.1B	$1.1B	$1.5B	$1.4B	$1.3B	$1.3B	$1.3B	$1.1B	$1.1B	$946M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ATR viewer.

ATR Metric Deep Dives

Other Companies in MEDICAL INSTRUMENTS & SUPPLIES

MDLN · Medline Inc. Class A Common Stock — $43 billion
ALC · Alcon AG — $31 billion
AVTR · Avantor Inc — $10 billion
RGEN · Repligen Corporation — $10 billion
MMED · MiniMed Group, Inc. Common Stock — $6 billion
BLCO · Bausch + Lomb Corp — $6 billion
STVN · Stevanato Group SpA — $6 billion
MMSI · Merit Medical Systems Inc — $5 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← ATPC All “A” companies ATRA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.